Loading...
Loading...
NAUT| Name | Value |
|---|---|
| Revenues | 0.0M |
| Cost of Revenue | 1.4M |
| Gross Profit | -1.4M |
| Operating Expense | 19.0M |
| Operating I/L | -15.8M |
| Other Income/Expense | -0.0M |
| Interest Income | 3.2M |
| Pretax | -15.8M |
| Income Tax Expense | -3.2M |
| Net Income/Loss | -15.8M |
Nautilus Biotechnology, Inc. is a life sciences company focused on developing the Nautilus Platform, a proteomics platform designed to quantify and unravel the complexities of the proteome. The platform offers an end-to-end solution, including instruments, consumables, and software analysis, to enable researchers to gain insights into the proteome. By providing this platform technology, Nautilus Biotechnology aims to generate revenue through the sale of instruments, consumables, and software licenses to research institutions and biotechnology companies.
